Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/11/2025

Management of Ischemic Priapism

Diagnosis and Immediate Treatment

  • The American Urological Association recommends immediate urologic emergency treatment with corporal aspiration and intracavernosal phenylephrine injection for ischemic priapism, regardless of the underlying medication causes or testosterone therapy 1, 2
  • Cavernosal blood gas analysis is the gold standard for diagnosis, with ischemic priapism showing pO2 <30 mmHg, pCO2 >60 mmHg, and pH <7.25 1, 2
  • If blood gas is unavailable, color Doppler ultrasound showing minimal to absent cavernosal arterial flow can be used for diagnosis 1
  • Physical exam will reveal completely rigid corpora cavernosa with spared glans and corpus spongiosum, and the patient will experience significant pain, confirming ischemic type 2, 3

Treatment Outcomes and Timing

  • The combination of corporal blood aspiration and intracavernosal phenylephrine injection has a 43-81% success rate 1, 2
  • Repeat sympathomimetic injections should be performed prior to considering surgical intervention, with a maximum dose of 1000 mcg of phenylephrine within the first hour 1, 3
  • Critical timing: Risk of permanent erectile dysfunction increases significantly after 24 hours and approaches 90% after 48 hours 1

Surgical Intervention

  • If repeated phenylephrine injections fail, proceed to surgical shunting, starting with distal shunts (Winter, Ebbehoj, T-shunt) which have 60-80% success rates 1
  • Proximal shunts (Quackels, Grayhack) are reserved for distal shunt failures but carry higher erectile dysfunction risk 1

Prevention of Recurrent Episodes

  • Implement preventive pharmacotherapy to reduce future priapism episodes, considering PDE5 inhibitors for stuttering/recurrent priapism prevention 1
  • Educate patient on self-administration of intracavernosal phenylephrine at home for episodes not yet meeting 4-hour criteria 2
  • Patient should be counseled on injection site, dosing, systemic side effects, and duration of erection before self-injection 4, 5

Medication Management

  • Testosterone itself can contribute to priapism risk, but do not discontinue testosterone acutely during the emergency 1
  • After priapism resolution, discuss with endocrinology whether testosterone dose adjustment is warranted 4
  • Daily alcohol consumption may have contributed to priapism risk through multiple mechanisms, including medication interactions and vascular effects, and should be addressed as part of comprehensive prevention strategy 3

REFERENCES

1

Ischemic Priapism Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Ischemic and Non-Ischemic Priapism Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025